Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

AGM Statement

16 Jun 2022 07:00

RNS Number : 0160P
Anpario PLC
16 June 2022
 

Anpario plc

("Anpario" or the "Company")

 

AGM Statement

 

Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM later today. Kate Allum, Chairman, will make the following statement:

 

"Group sales for the five months to 31 May 2022 are just ahead of last year which we consider a good performance given China's recent Covid lockdown and the Russia - Ukraine conflict, both of which have affected our sales performance. As anticipated, we experienced significant raw material price inflation, which has remained at elevated levels, and combined with historically high logistics costs has led to a fall in our gross margins. We have though, as a priority, been successfully passing on this inflation through planned sales price increases and overheads are being closely managed.

 

To mitigate the continued disruption in global supply chains we have increased finished goods inventory in our subsidiaries worldwide and increased raw material stockholding at our production site following the recent expansion and upgrade in storage capacity. It is vital that we maintain continuity of supply to our customers who are experiencing significant cost pressures from the high price of animal feed. Encouragingly, international travel and tourism is increasing and should lead to a corresponding uplift in meat consumption. 

 

We are excited by the potential of both existing and new products including pHorce® which is proving its value to pig producers worried about virus-contaminated feed and as a replacement for zinc oxide (ZnO) which is banned in piglet diets from June 2022 in the European Union. Our new omega 3 supplement, Optomega® Algae, has generated a lot of interest due to its sustainable source, from which we expect to convert this interest into growing sales. The Company continues to invest in both product technology and its global sales channels to deliver effective innovative solutions for the animal production industry.

 

We expect the challenging environment to continue until the end of the year, but Anpario's broad range of products, geographic diversity and strong financial position makes for a robust business and gives us confidence in our ability to navigate the current uncertainties and continue with the profitable development of the Company."

 

The Company's interims for the six months period ended 30 June 2021 are expected to be announced on 14 September 2021.

 

 

 

Enquiries:

 

Anpario plc

Richard Edwards, CEO

+44(0) 777 6417 129

Marc Wilson, Group Finance Director

+44(0) 1909 537380

 

Peel Hunt LLP (Nomad and broker)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Lalit Bose

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFFFIFRIIELIF
Date   Source Headline
20th Jul 20221:02 pmRNSBlock listing Interim Review
7th Jul 20222:59 pmRNSHolding(s) in Company
22nd Jun 202211:24 amRNSAGM Statement
16th Jun 20226:00 pmRNSResult of AGM
16th Jun 20227:00 amRNSAGM Statement
27th May 202212:56 pmRNSHolding(s) in Company
24th May 20221:10 pmRNSHolding(s) in Company
11th May 20227:00 amRNSNotice of AGM
10th May 20223:55 pmRNSHolding(s) in Company
5th May 20223:18 pmRNSHolding(s) in Company
4th May 20221:14 pmRNSTotal Voting Rights
28th Apr 202211:17 amRNSHolding(s) in Company
20th Apr 20221:49 pmRNSHolding(s) in Company
19th Apr 20223:47 pmRNSHolding(s) in Company
8th Apr 20227:00 amRNSDirectorate Change
6th Apr 202210:10 amRNSHolding(s) in Company
6th Apr 202210:09 amRNSTotal Voting Rights
1st Apr 20223:41 pmRNSHolding(s) in Company
25th Mar 202210:40 amRNSHolding(s) in Company
24th Mar 202212:57 pmRNSGrant of share awards
22nd Mar 20225:08 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amRNSFinal Results
8th Mar 20222:35 pmRNSBlock listing Interim Review
8th Mar 20222:34 pmRNSTotal Voting Rights
26th Jan 20227:00 amRNSFull Year Trading Statement
3rd Dec 20217:00 amRNSUK patent granted for Orego-stim
18th Nov 20211:17 pmRNSHolding(s) in Company
10th Nov 20217:00 amRNSNew Commitment to Sustainable Operations
3rd Nov 202112:04 pmRNSTotal Voting Rights
1st Nov 202110:03 amRNSHolding(s) in Company
26th Oct 20214:28 pmRNSHolding(s) in Company
12th Oct 20217:20 amRNSDirector/PDMR Shareholding
15th Sep 202111:51 amRNSHalf-year Report - Replacement
15th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20219:52 amRNSTotal Voting Rights
20th Jul 20219:42 amRNSBlock listing Interim Review
9th Jul 20212:16 pmRNSAnpario receives “Community Business Hero Award"
17th Jun 20211:24 pmRNSResult of AGM
17th Jun 20217:00 amRNSAGM Statement
7th Jun 20213:58 pmRNSDirector/PDMR Shareholding
24th May 20219:48 amRNSHolding(s) in Company
18th May 20217:00 amRNSNotice of AGM
4th May 20214:16 pmRNSDirector/PDMR Shareholding
4th May 20214:10 pmRNSTotal Voting Rights
28th Apr 20214:00 pmRNSDirector/PDMR Shareholding
22nd Apr 20214:05 pmRNSDirector/PDMR Shareholding
19th Apr 20217:00 amRNSBoard update
13th Apr 20219:17 amRNSHolding(s) in Company
13th Apr 20219:17 amRNSHolding(s) in Company
6th Apr 20211:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.